Neuralink encountered a problem with the implant in its first human patient, Noland Arbaugh, that reduced the amount of data it could capture from his brain, according to a blog post the company ...

Only about 15 percent of the electrode-bearing threads implanted in the brain of Neuralink's first human brain-chip patient ...

Neuralink on Wednesday said part of its brain implant malfunctioned in the weeks following its first in-human procedure. The company has built a brain-computer interface that could help patients ...

In our content, we occasionally include affiliate links. Should you click on these links, we may earn a commission, though this incurs no additional cost to you. Your use of this website signifies ...

In 2016, Noland Arbaugh suffered a spinal cord injury while swimming in a lake. The details are fuzzy, but what he remembers is rushing toward the water with his friends, diving in, and hitting ...

Elon Musk’s first human experiment with a computerized brain device developed significant flaws, but the subject, who is paralyzed, has few regrets. By Christina Jewett Just four months ago ...

Neuralink reported data loss issue with brain chip implanted in Noland Arbaugh. They enhanced the user interface for better cursor movements in response to the issue. The Neuralink implant ...

Noland Arbaugh has a computer chip embedded in his skull and an electrode array in his brain. But Arbaugh, the first user of ...

Noland Arbaugh became the first human patient to receive the Neuralink device. The 30-year-old quadriplegic man who opted to become the first human to receive Elon Musk's Neuralink brain implant ...

Thirty-year-old Noland Arbaugh says the Neuralink chip has let him “reconnect with the world” ...

Neuralink, the brain-computer interface startup led by Elon Musk, has achieved another milestone as the U.S. Food and Drug Administration (FDA) gave a green light for the company to implant its ...

Neuralink’s first human trial revealed that tiny brain implant wires had retracted, an issue previously known from animal tests. Despite the problem, the company did not redesign the device, relying ...